Exelixis Inc (EXEL.O)

EXEL.O on Nasdaq

4.15USD
2:14pm EDT
Price Change (% chg)

-- (+0.00%)
Prev Close
$4.15
Open
$4.16
Day's High
$4.20
Day's Low
$4.08
Volume
1,430,673
Avg. Vol
3,865,500
52-wk High
$8.41
52-wk Low
$3.02

EXEL.O

Chart for EXEL.O

About

Exelixis, Inc. (Exelixis) is a biotechnology company engaged in developing small molecule therapies for the treatment of cancer. The Company is focusing its resources and development efforts on cabozantinib (XL184). It also has a portfolio of other compounds. Cabozantinib is the inhibitor of MET in clinical development and is... (more)

Overall

Beta: 2.31
Market Cap (Mil.): $809.71
Shares Outstanding (Mil.): 195.11
Dividend: --
Yield (%): --

Financials

  EXEL.O Industry Sector
P/E (TTM): -- 150.73 33.58
EPS (TTM): -1.51 -- --
ROI: -70.92 -3.09 17.30
ROE: -286.51 -7.34 18.05
Search Stocks

Competitors

  Price Change
AstraZeneca plc (AZN.L) 4,449.00p -18.50
Pfizer Inc. (PFE.N) $29.50 +0.29
ArQule, Inc. (ARQL.OQ) $1.29 --
GlaxoSmithKline plc (GSK.L) 1,463.00p +15.50
Algeta ASA (ALGETA.OL) -- --

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks